Skip to main content

Table 5 Cognitive debriefing child participants characteristics

From: Development and content validation of a self-completed, electronic Pediatric Asthma Symptom Diary

Characteristics Philadelphia, PA, US
Round 1
(n = 8)
Southfield, MI, US
Round 2a
(n = 13)
Total
(N = 21)
Age, years
 Mean 8.5 8.0 8.2
 Range 6–11 6–11 6–11
Sex, n (%)
 Male 4 (50) 5 (38) 9 (43)
 Female 4 (50) 8 (62) 12 (57)
Race, n (%)
 Black 4 (50) 8 (62) 12 (57)
 White 3 (38) 4 (31) 7 (33)
 Otherb 1 (13) 1 (8) 2 (10)
Hispanic ethnicity, n (%)c
 Yes 1 (13) 0 (0) 1 (5)
 No 7 (88) 13 (100) 20 (95)
Asthma severity, n (%)d
 Mild 2 (25) 3 (23) 5 (24)
 Moderate 2 (25) 7 (54) 9 (43)
 Severe 4 (50) 3 (23) 7 (33)
Reading skill level, n (%)
 Can read alone 5 (63) 9 (69) 14 (67)
 Can read but with some difficulty 2 (25) 2 (15) 4 (19)
 Can only read a few words 1 (13) 2 (15) 3 (14)
  1. ePASD electronic Pediatric Asthma Symptom Diary, MI Michigan, PA Pennsylvania, US United States
  2. aTwo of the 13 children (ages 6 [can read a few words] and 7 [can read but with difficulty]) participating in Round 2 interviews were unable to complete the cognitive interview for the ePASD nighttime diary; however, both of these children were able to successfully self-complete all of the ePASD questions on the tablet
  3. bRound 1 participant that selected “Other” for race specified mixed race of White/Black; Round 2 participant that selected “Other” for race specified mixed race of White/Asian
  4. cEthnicity was collected separately from race
  5. dAsthma severity levels defined based on Global Initiative for Asthma 2018 guidelines and child’s daily asthma controller medication use at screening as follows: Mild = low-dose inhaled corticosteroid (ICS) alone or leukotriene receptor antagonist (LTRA) alone; Moderate = low-dose ICS/ long-acting beta agonist (LABA), low-dose ICS + LTRA, medium-dose ICS alone or high-dose ICS alone; Severe = medium-dose ICS/LABA, medium-dose ICS + LTRA, high-dose ICS/LABA or high-dose ICS + LTRA